Copyright
©The Author(s) 2024.
World J Cardiol. Jan 26, 2024; 16(1): 27-39
Published online Jan 26, 2024. doi: 10.4330/wjc.v16.i1.27
Published online Jan 26, 2024. doi: 10.4330/wjc.v16.i1.27
Fischer et al[19] | Schardong et al[20] | Kitamura et al[21] | Fontes Cerqueira et al[22] | Fontes Cerqueira et al[23] | Sumin et al[24] | Rengo et al[25] | Cerqueira et al[26] | Takino et al[27] | Sumin et al[28] | |
Eligibility criteria1 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Random allocation | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Concealed allocation | √ | √ | √ | √ | √ | |||||
Baseline comparability | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
Blinded subjects | √ | √ | √ | √ | ||||||
Blinded therapists | ||||||||||
Blinded assessors | √ | √ | √ | √ | √ | √ | ||||
Adequate follow-up | √ | √ | √ | √ | √ | |||||
Intention-to-treat analysis | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
Between-group comparisons | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Point estimates and variability | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Total score | 8/10 | 9/10 | 7/10 | 6/10 | 7/10 | 6/10 | 3/10 | 7/10 | 9/10 | 6/10 |
Ref. | Groups | Males/ | Age (yr) | Weight (kg) | Height (cm) | BMI | Type of surgery |
Fischer et al[19] | NMES (n = 27); CG (n = 27) | 18/9; 20/7 | 63.3 ± 15.5; 69.7 ± 13.1 | NA | NA | 27.6 ± 3.7; 27.7 ± 4.6 | Aortic valve replacement; CABG; Heart transplantation; Other cardiothoracic surgery; Mitral valve replacement; Mitral valve reconstruction; Tricuspid valve reconstruction; Bentall surgery |
Schardong et al[20] | FES (n = 10); CG (n = 10) | 7/3; 7/3 | 60 ± 7.3; 63.5 ± 5 | NA | NA | 27.3 ± 3.1; 29.1 ± 6.2 | CABG; Heart valve surgery |
Kitamura et al[21] | NMES (n = 60); CG (n = 59) | 39/21; 37/22 | 67 (55-74); 70 (61-77) | NA | NA | 25.5 (20.4-24.8); 22.3 (20.4-24.9) | CABG; Valvular surgery; Thoracic Aorta |
Fontes Cerqueira et al[22] | NMES (n = 26); CG (n = 33) | 18/8; 23/10 | 41.8 ± 13.17; 42.21 ± 14.36 | 66.12 ± 13.29; 61.85 ± 12.69 | 160 ± 6; 165 ± 8 | 25. ± 4.72; 21.96 ± 4.2 | Mitral valve replacement; Aortic valve replacement; Mitral valve reconstruction; Aortic valve reconstruction; Mitral valve replacement + Aortic valve reconstruction |
Fontes Cerqueira et al[23] | NMES (n = 15); CG (n = 15) | 9/6; 5/10 | 49.87 ± 14.37; 50.93 ± 14.56 | NA | NA | NA | CABG; Valve replacement; CABG + Valve replacement |
Sumin et al[24] | NMES (n = 18); CG (n = 19) | 12/6; 13/6 | 61.5 [52-70]; 64 [60-68] | NA | NA | 28.4 [25.2-30.9]; 28.4 [25.8-32.5] | CABG; Aortic valve replacement; Mitral valve replacement; CABG + valve replacement; Multivalve operations; Bentall surgery; Aortic dissection; Heart transplantation |
Rengo et al[25] | NMES (n = 18); CG (n = 19) | 16/2; 17/2 | 66.5 ± 1.6; 66.2 ± 1.4 | 89.4 ± 2.7; 90.9 ± 3.8 | 173 ± 1; 176 ± 3 | 29.7 ± 0.8; 29.0 ± 0.8 | CABG; CABG + Valve replacement |
Cerqueira et al[26] | NMES (n = 23); CG (n = 22) | 12/11; 15/7 | 47.8 ± 13.9; 46.4 ± 13.5 | 72.3 ± 14.8; 68.5 ± 13.6 | 163.1 ± 10.4; 165.2 ± 7.2 | 27.2 ± 4.9; 25.1 ± 4.5 | CABG; Aortic valve replacement; Mitral valve replacement; Mitral valve replacement; + Aortic valve reconstruction |
Takino et al[27] | NMES (n = 90); CG (n = 90) | 61/29; 63/27 | 74 ± 5; 74 ± 5 | NA | NA | 19.8 (18.0-21.8); 19.3 (18.2-20.8) | CABG; Valvular surgery; Thoracic aorta; Other surgery; Combined surgery |
Sumin et al[28] | NMES n = 62); CG (n = 60) | 44/18; 39/21 | 62.0 [57.5-66.6]; 63.5 [59.0-69.0] | NA | NA | 27.4 [25.4-31.5]; 28.7 [25.9-33.3] | Prehabilitation (before cardiac surgery) |
Ref. | Interventions by group | Frequency | Session duration | Intervention Duration | Outcomes | Main results | Adverse events |
Fischer et al[19] | NMES: biphasic rectangular pulses at 66 Hz, pulse duration 0.4 ms, duty cycle 3.5 s on and 4.5 s off to quadriceps muscle bilaterally. CG: stimulator electrodes were applied but no electricity was delivered | 2 times/d for 7 d/wk | 30 min | From POD 1 until ICU exit or POD 14 | Muscle layer thickness, Muscle strength; Functional capacity | No significant effect on MLT. | 5 patients in the NMES group mentioned a feeling of discomfort |
Schardong et al[20] | 1FES: symmetric biphasic rectangular pulses at 15 Hz, pulse duration 0.5 ms, duty cycle 5 s on and 10 s off to vastus medialis and lateralis muscle bilaterally. CG: Stimulator electrodes were applied but no electricity was delivered | 2 times/wk | 40 min | 8 wk | Functional capacity; Muscle strength; Muscle endurance; Muscle mass | ↑ Distance to 6MWT in the FES group by 11.0% (49.6 m, 95%CI: 15.9-83.3) and in the CG by 10.4% (41.5 m, 95%CI: 7.8-75.2) with no significant between-groups. ↑ muscle strength (7.2 kg, 95%CI: 0.2-14.2). ↑ Muscle endurance (2.2 repetitions, 95%CI: 1.0-3.4) | No complications |
Kitamura et al[21] | NMES: Symmetric biphasic square pulses, duty cycle 0.4 s on and 0.6 s off, 10 pulse trains (10 s) with 30 s intervals to quadriceps femoris and triceps surae muscle bilaterally. Usual postoperative rehabilitation program. CG: Usual postoperative rehabilitation program | 1 time/d | 30 min | 3 d before surgery and from POD 1 to POD 5 (8 sessions) | The mean concentration of 3-MH/Cre; Physical function; Walking speed; Grip strength | No significant difference in the mean 3-MH/Cre from POD 1 to POD 6 between groups (225.3 [204.0-248.3] μmol/g vs 227.3 [206.3-259.9] μmol/g, P = 0.531). No significant difference in the KEIS on POD 7 between groups (0.44 ± 0.13 kgf/kg vs 0.41 ± 0.12 kgf/kg, P = 0.149. No significant difference in walking speed between groups (1.04 ± 0.24 m/s vs 0.99 ± 0.23 m/s, P = 0.294). No significant difference in grip strength between groups (29.1 ± 10.5 kg vs 26.9 ± 8.7 kg, P = 0.213) | 1 patient mentioned muscle soreness |
Cerqueira et al[22] | NMES: Stimulation at 50 Hz, duration 400 ms duty cycle 3 s on and 9 s off, to quadriceps and gastrocnemius muscle bilaterally. Regular physiotherapy care. CG: Usual physiotherapy care twice a day | 2 times/d | 60 min | from POD 1 to POD 5 | Ambulation ability; Muscle strength; Functional independence; Quality of life | No significant difference in distance walked (95%CI: -64.87 to 65.97) and walking speed (95%CI: -0.55 to 0.57) between groups. No significant difference in muscle strength in the upper- limb, lower limb, and total MRC values, functional independence, and quality of life between groups | 2 patients reported hypotension, and 1 patient complained of pain |
Cerqueira et al[23] | NMES: Stimulation at 50 Hz, duration 200 ms duty cycle 3 s on and 9 s off, to quadriceps and gastrocnemius muscle bilaterally. Regular physiotherapy care. CG: stimulator electrodes were applied but no electricity was delivered | Once during the first 48 h of ICU stay | 60 min | 60 min | Hemodynamic responses; Respiratory responses | No difference in heart rate, systolic blood pressure, diastolic blood pressure, mean blood pressure respiratory rate, and oxygen saturation between groups | No complications |
Sumin et al[24] | NMES: biphasic rectangular pulses at 45 Hz, duty cycle 12 s on and 5 s off to quadriceps muscle bilaterally. CG: Usual postoperative rehabilitation program | 1 time/d | 90 min | from POD 3 to exit the hospital (12 sessions or more) | Knee extensors strength; Handgrip strength; Knee flexor strength CSA of quadriceps femoris | ↑ Knee extensors strength in the NMES group [28.1 (23.8; 36.2) kg on the right and 27.45 (22.3; 33.1) kg on the left] vs CG [22.3 (20.1; 27.1) and 22.5 (20.1; 25.9) kg, respectively; P < 0.001]. No difference in handgrip strength, knee flexor strength, quadriceps CSA, and 6MWT at discharge between groups | Non mentioned |
Rengo et al[25] | 2NMES: biphasic rectangular pulses at 25 Hz, pulse duration 400 ms, duty cycle 10 s on and 30 s off to quadriceps muscle bilaterally. CG: no intervention | 1 times/d for 5 d/wk | 45 min | 4 wk | Physical function Mental and physical health | From discharge to 4-wk post-discharge: No significant interaction effect for total SPPB score (P = 0.11; ηp2 = 0.073; CG: 2.89 ± 0.50 vs NMES: 4.11 ± 0.54 units). Time effects for 6MWT distance (P < 0.01; ηp2 = 0.207; CG: 194 ± 18 vs NMES: 267 ± 16 m) and 6MWT power output (P = 0.01; ηp2 = 0.168; CG: 0.4 ± 0.1 vs NMES: 0.6 ± 0.1 W; P = 0.01) | No complications |
Cerqueira et al[26] | NMES: Stimulation at 50 Hz, duration 400 ms duty cycle 3 s on and 9 s off, to rectus femoris and gastrocnemius muscle bilaterally. Regular physiotherapy care twice a day. CG: Usual physiotherapy care twice a day | 2 times/d | 60 min | From POD 1 to POD 5 | Distance walked; Gait speed; Lactate levels Muscle strength Electromyographic activity of the rectus femoris; Functional Independence Measure | No significant difference in the distance walked (P = 0.650) between NMES group (239.06 ± 88.55) and CG (254.43 ± 116.67) as well as gait speed (P = 0.363), lactate levels (P = 0.302), knee extensor strength (P = 0.117), handgrip strength (P = 0.882), global muscle strength (P = 0.104), electromyographic activity (P = 0.179) and Functional Independence Measure (P = 0.059) | No complications |
Takino et al[27] | NMES: Biphasic symmetric square pulses at 20 and 200 Hz, duty cycle 0.4 s on and 0.6 s off to vastus lateralis, vastus medialis and triceps surae muscle bilaterally. Standard post- surgical rehabilitation. CG: Standard post- surgical rehabilitation. | 1 time/d | 60 min | from POD 1 to POD 7 | % change in isometric knee strength; % change in usual and maximum walking speed; % change in grip strength | ↓ %ΔIKES in the NMES than CG [NMES: Mean -2%, 95% confidence interval (CI) -6 to 1; CG: -13%, 95% CI -17 to -9, P < 0.001]. ↓ %ΔMWS (P = 0.04). | Non mentioned |
Sumin et al[28] | NMES: rectangular pulses at 45 Hz, duty cycle 12 s on and 5 s off to quadriceps muscle bilaterally. Standard preoperative rehabilitation program; CG: Standard preoperative rehabilitation program | 1 time/d | 90 min | from the 2nd day of hospital stay until the day before surgery (7–10 sessions) | Exercise capacity; Muscle strength | ↑ in KES, KFS, and 6MWT distance (all P < 0.001) in the NMES group compared to the CG. Slight ↑ in HS to the NMES group and slight ↓ to the CG but not statistically significant | No complications |
- Citation: Kourek C, Kanellopoulos M, Raidou V, Antonopoulos M, Karatzanos E, Patsaki I, Dimopoulos S. Safety and effectiveness of neuromuscular electrical stimulation in cardiac surgery: A systematic review. World J Cardiol 2024; 16(1): 27-39
- URL: https://www.wjgnet.com/1949-8462/full/v16/i1/27.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i1.27